HomeCLYM • NASDAQ
add
Climb Bio Inc
Previous close
$1.20
Day range
$1.20 - $1.33
Year range
$1.05 - $9.58
Market cap
87.17M USD
Avg Volume
153.61K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.02M | 665.99% |
Net income | -20.78M | -1,124.57% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 98.06M | -6.64% |
Total assets | 200.74M | 83.60% |
Total liabilities | 7.36M | 149.32% |
Total equity | 193.38M | — |
Shares outstanding | 67.58M | — |
Price to book | 0.42 | — |
Return on assets | -27.54% | — |
Return on capital | -28.33% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -20.78M | -1,124.57% |
Cash from operations | -15.43M | -748.49% |
Cash from investing | -42.75M | -410.89% |
Cash from financing | — | — |
Net change in cash | -58.21M | -588.37% |
Free cash flow | -8.52M | -343.38% |
About
Founded
2018
Headquarters
Website
Employees
18
